Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation

被引：0
|
作者：
I Petruskevicius
M Ludvigsen
R Hjortebjerg
B S Sørensen
P Kamper
M Vase
L G Oestgaard
B Nielsen
B Honoré
M Bjerre
G A Rabinovich
F A d'Amore
机构：
[1] Aarhus University Hospital,Department of Haematology
[2] Aarhus University,Department of Biomedicine
[3] Aarhus University Hospital,Department of Clinical Medicine
[4] Aarhus University Hospital,Department of Immunology
[5] Institute of Biology and Experimental Medicine (IBYME),undefined
[6] National Council Research (CONICET) and School of Exact and Natural Sciences,undefined
[7] University of Buenos,undefined
[8] Aires,undefined
来源：
Bone Marrow Transplantation | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1387 / 1390
页数：3
相关论文
共 50 条
  • [1] Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation
    Petruskevicius, I.
    Ludvigsen, M.
    Hjortebjerg, R.
    Sorensen, B. S.
    Kamper, P.
    Vase, M.
    Oestgaard, L. G.
    Nielsen, B.
    Honore, B.
    Bjerre, M.
    Rabinovich, G. A.
    d'Amore, F. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (10) : 1387 - 1390
  • [2] GALECTIN-1 AS A NOVEL PROGNOSTIC BIOMARKER IN HAEMATOLOGIC MALIGNANCIES TREATED WITH NON-MYELOABLATIVE HAEMOPOIETIC STEM CELL TRANSPLANTATION
    Petruskevicius, I.
    Ludvigsen, M.
    Kamper, P. Martin Hjornet
    Hjortebjerg, R. Moller
    Sorensen, B. Samuelsen
    Nielsen, B.
    Honore, B.
    d'Amore, F. Annibale
    BONE MARROW TRANSPLANTATION, 2014, 49 : S279 - S279
  • [3] Update on non-myeloablative stem cell transplantation for hematologic malignancies
    S. Giralt
    International Journal of Hematology, 2002, 76 : 176 - 183
  • [4] Update on non-myeloablative stem cell transplantation for hematologic malignancies
    Giralt, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 176 - 183
  • [5] Update on non-myeloablative stem cell transplantation for hematologic malignancies
    Giralt, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 : 368 - 375
  • [6] Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies
    Mielcarek, M
    Storb, R
    CANCER TREATMENT REVIEWS, 2003, 29 (04) : 283 - 290
  • [7] Safety and efficacy of autologous non-myeloablative hemopoietic stem cell transplantation
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (05) : 457 - 457
  • [8] Non-myeloablative hematopoietic stem cell transplantation for hematological malignancies.
    Yamane, T
    Aoyama, Y
    Hakamae, H
    Hasegawa, T
    Yamamura, R
    Sakamoto, C
    Terada, Y
    Koh, G
    Ohta, K
    Hino, M
    BLOOD, 2003, 102 (11) : 473B - 473B
  • [9] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [10] Non-myeloablative stem cell transplantation for the treatment of hematologic malignancies and metastatic solid tumors: a single center experience
    Cetin, M
    Unal, A
    Eser, B
    Altuntas, F
    Er, O
    Patiroglu, T
    Canoz, O
    Ozkul, Y
    Kaplan, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S158 - S159
12345